1T-AL-LAD, also known as 1-(thiophene-2-carbonyl)-AL-LAD, is a psychedelic lysergamide derivative which has been sold as a designer drug, first reported in April 2024.[1] It is believed to act as a prodrug for AL-LAD in a similar manner to how 1P-LSD acts as a prodrug for LSD.[2]

Use and effects

Interactions

Chemistry

Analogues

Analogues of 1T-AL-LAD include AL-LAD, 1P-AL-LAD, 1cP-AL-LAD, 1T-LSD, 1S-LSD, and 1P-ETH-LAD, among others.

Society and culture

Canada

1T-AL-LAD is not an explicitly nor implicitly controlled substance in Canada as of 2025.[3]

United States

1T-AL-LAD is not an explicitly controlled substance in the United States.[4] However, it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption.

See also

References

  1. ↑ "1T-AL-LAD". АИПСИН (in Russian). Retrieved 1 January 2026.
  2. ↑ Okada Y, Segawa H, Yamamuro T, Kuwayama K, Tsujikawa K, Kanamori T, et al. (June 2024). "Synthesis and analytical characterization of 1-(2-thienoyl)-6-allyl-nor-d-lysergic acid diethylamide (1T-AL-LAD)". Drug Testing and Analysis. 17 (4): 494–501. doi:10.1002/dta.3747. PMID 38922764.
  3. ↑ "Controlled Drugs and Substances Act". Department of Justice Canada. 5 December 2025. Retrieved 20 January 2026.
  4. ↑ Orange Book: List of Controlled Substances and Regulated Chemicals (January 2026) (PDF), United States: U.S. Department of Justice: Drug Enforcement Administration (DEA): Diversion Control Division, January 2026
source: https://en.wikipedia.org/wiki/1T-AL-LAD